Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 25, No. 3, 2007
Issue release date: September 2007
Section title: Liver and Pancreas
Dig Dis 2007;25:285–288

Pancreatic Cancer Is ‘Always Non-Resectable’

Mönkemüller K. · Fry L.C. · Malfertheiner P.
Division of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke Medical School, University of Magdeburg, Magdeburg, Germany
email Corresponding Author

Klaus Mönkemüller, MD, Department of Gastroenterology,

Hepatology and Infectious Diseases, Universitätsklinikum Magdeburg

Otto von Guericke University, Leipziger Strasse 44, DE–39120 Magdeburg (Germany)

Tel. +49 391 671 3100, Fax +49 391 671 3105

E-Mail klaus.moenkemueller@medizin.uni-magdeburg.de


  1. Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004;363:1049–1057.
  2. Böhmig M, Rosewicz S: Pancreatic carcinoma. Z Gastroenterol 2004;42:261–268.
  3. Willett CG, Czito BG, Bendell JC, Ryan DP: Locally advanced pancreatic cancer. J Clin Oncol 2005;23:4538–4544.
  4. Saif MW: Pancreatic cancer: highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, 2006. JOP 2006;7:337–348.
    External Resources
  5. Eloubeidi MA, Desmond RA, Wilcox CM, Wilson RJ, Manchikalapati P, Fouad MM, Eltoum I, Vickers SM: Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 2006;192:322–329.
  6. Brenner H, Stegmaier C, Ziegler H: Long-term survival of cancer patients in Germany achieved by the beginning of the third millennium. Ann Oncol 2005;16:981–986.
  7. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE: Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128–1137.
  8. Van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, Obertop H, Gouma DJ: Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005;242:781–788.
  9. Fernandez JA, Parrilla P: What are the main errors made by surgeons in the management of pancreatic cancer? Cir Esp 2006;79:215–223.
    External Resources
  10. Postier RG: The challenge of pancreatic cancer. Am J Surg 2003;186:579–582.
  11. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW: Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586–594.
  12. Smeenk HG, Tran TC, Erdmann J, van Eijck CH, Jeekel J: Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg 2005;390:94–103.
  13. Michaud DS: Epidemiology of pancreatic cancer. Minerva Chir 2004;59:99–111.
  14. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82:111–115.
  15. Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W, Friess H, Büchler MW: Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005;92:547–556.
  16. Freeny PC: Pancreatic carcinoma: imaging update 2001. Dig Dis 2001;19:37–46.
  17. Ishikawa O, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imaoka S, Iwanaga T: Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215–220.
  18. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I: An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72:2118–2123.
  19. Gudjonsson B: Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995;181:483–503.
  20. Picozzi VJ, Kozarek RA, Traverso LW: Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003;185:476–480.
  21. Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF: An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003;196:954–964.
  22. Liu SL, Friess H, Kleeff J, Ji ZL, Büchler MW: Surgical approaches for resection of pancreatic cancer: an overview. Hepatobiliary Pancreat Dis Int 2002;1:118–125.
    External Resources
  23. Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW, Terpstra OT, Zijlstra JA, Klinkert P, Jeekel H: Pylorus-preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004;240:738–745.